Skip to main content

Table 1 Patient characteristics of the study population

From: Cell-free DNA methylation markers for differential diagnosis of hepatocellular carcinoma

 

HCC

Cirrhosis

Healthy Individuals

Training

Validation

P value

Training

Validation

P value

Training

Validation

P value

Total, n

120

67

 

92

111

 

290

242

 

Age, years

 Mean ± SD

53(24-83)

54(23-74)

0.599

48(26-81)

52(22-82)

0.005

50(21-89)

50(18-79)

0.633

AFP, ng/ml#

 Negative, ≤20 ng/ml

41

20

0.869

53

65

0.617

83

63

 

 Positive, >20 ng/ml

77

42

21

32

0

0

 

 UNK

2

5

 

18

14

 

207

176

 

Gender

         

 Male

106

55

0.273

74

89

0.86

236

192

0.584

 Female

14

12

17

22

54

50

 UNK

   

1

     

HBV infection*

 No

11

9

0.461

22

9

0.003

60

54

0.896

 Yes

105

57

67

98

65

56

 UNK

4

1

 

3

4

 

165

132

 

Child-Pugh class

 A

102

54

0.491

14

39

0.004

   

 B

15

9

33

37

  

 C

1

2

44

35

   

 UNK

2

2

 

1

     

BCLC stage

 0

7

3

0.698

      

 A

65

34

     

 B

18

8

     

 C

27

18

      

 D

3

4

      
  1. #AFP was not reported by some healthy individuals; *HBV status was not reported by some healthy individuals
  2. AFP alpha-fetorprotein, BCLC Barcelona Clinic Liver Cancer, HBV hepatitis B virus, HCC hepatocellular carcinoma, UNK unknown, SD standard deviation